Edition:
India

Kangmei Pharmaceutical Co Ltd (600518.SS)

600518.SS on Shanghai Stock Exchange

21.98CNY
12:29pm IST
Change (% chg)

¥0.06 (+0.27%)
Prev Close
¥21.92
Open
¥21.80
Day's High
¥22.16
Day's Low
¥21.54
Volume
24,143,968
Avg. Vol
21,291,398
52-wk High
¥23.90
52-wk Low
¥16.95

Chart for

About

Kangmei Pharmaceutical Co., Ltd is a China-based company, principally engaged in the manufacture and sales of pharmaceutical products. The Company's principal products are Chinese medicines, including American ginseng, notoginseng powder, salvia powder, radix codonopsis pilosulae, maltiflower knotweed, angelica and lonicera... (more)

Overall

Beta: 0.74
Market Cap(Mil.): ¥99,330.61
Shares Outstanding(Mil.): 4,946.74
Dividend: 0.20
Yield (%): 1.02

Financials

  Industry Sector
P/E (TTM): -- 31.11 16.44
EPS (TTM): -- -- --
ROI: -- 14.85 10.61
ROE: -- 16.31 14.21

BRIEF-Kangmei Pharma Signs Agreement To Set Up Hospital With Partners

* SAYS IT SIGNS AGREEMENT TO INVEST ABOUT 1.08 BILLION YUAN ($165.60 million) TO SET UP HOSPITAL WITH PARTNERS Source text in Chinese: http://bit.ly/2Fk62Wa Further company coverage: ($1 = 6.5216 Chinese yuan renminbi) (Reporting by Hong Kong newsroom)

09 Jan 2018

BRIEF-Kangmei Pharmaceutical to acquire 80 pct stake in Huizhou-based pharmaceutical firm for 20.8 mln yuan

* Says it plans to acquire 80 percent stake in Huizhou-based pharmaceutical firm for 20.8 million yuan

29 Dec 2017

BRIEF-Kangmei Pharmaceutical to invest 50 mln yuan to set up wholly owned medical appliances firm

* Says its unit will invest 50 million yuan to set up a Beijing-based wholly owned medical appliances firm

29 Dec 2017

BRIEF-Kangmei Pharmaceutical in deal to invest 5 bln yuan in Guizhou

* SAYS IT SIGNS STRATEGIC AGREEMENT TO INVEST 5.0 BILLION YUAN ($756.06 million) IN GUIZHOU ON AREAS INCLUDING CHINESE MEDICINE RESEARCH, HEALTH BIG DATA Source text in Chinese: http://bit.ly/2Avc4TM Further company coverage: ($1 = 6.6132 Chinese yuan renminbi) (Reporting by Hong Kong newsroom)

06 Dec 2017

BRIEF-Kangmei Pharmaceutical's controlling shareholder issues 2017 second tranche exchangeable bonds worth 3 bln yuan

* Says its controlling shareholder issues 2017 second tranche non-public exchangeable bonds worth 3 billion yuan, with a term of three years

03 Dec 2017

BRIEF-Kangmei Pharmaceutical says controlling shareholder issues 2017 1st tranche non-public exchangeable bonds worth 2 bln yuan

* Says co's controlling shareholder, an industry investment firm, issued 2017 first tranche non-public exchangeable bonds worth 2 billion yuan, with term of 3 years

08 Nov 2017

BRIEF-Kangmei Pharmaceutical , BGI Genomics in strategic agreement

Oct 31 Kangmei Pharmaceutical Co Ltd , BGI Genomics Co LTd

31 Oct 2017

BRIEF-Kangmei Pharmaceutical issues 2017 third tranche mid-term bills worth 2 bln yuan

* Says it issued 2017 third tranche mid-term bills worth 2 billion yuan with a term of 5 years, and coupon rate of 5.47 percent

19 Sep 2017

BRIEF-Kangmei Pharmaceutical adopts new accounting policies

* Says it adopts new accounting policies regarding government subsidy, and non-current assets, disposal group and discontinued operations

29 Aug 2017

BRIEF-Kangmei Pharmaceutical unit plans two 80-pct-owned medical equipment JVs with partner

* Says its unit plans to invest totaling 16 million yuan to set up two medical equipment JVs with partner, and will own a 80 percent stake in JVs respectively

29 Aug 2017

Earnings vs. Estimates